These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Pediatric oncology. Jaffe N Am J Med Technol; 1973 Sep; 39(9):345-53. PubMed ID: 4356909 [No Abstract] [Full Text] [Related]
48. [Preliminary results of the therapeutic effectiveness in leukemia and malignant tumors in children of a new antineoplastic antibiotic: "daunomycin"]. Massimo L; Fossati-Guglielmoni A; Fortuna E Arch Ital Patol Clin Tumori; 1967; 10(1):3-19. PubMed ID: 4878269 [No Abstract] [Full Text] [Related]
49. The present status of cancer chemotherapy. Krakoff IH Med Clin North Am; 1971 May; 55(3):683-701. PubMed ID: 4102661 [No Abstract] [Full Text] [Related]
50. The use of cytotoxic drugs in the surgery of malignant disease. Watt J J Bone Joint Surg Br; 1968 Aug; 50(3):511-23. PubMed ID: 4303179 [No Abstract] [Full Text] [Related]
51. [Treatment of systemic hemolymphopathies and of epithelial and connective-tissue neoplasms with a methylhydrazine derivative]. Zarrilli D; Perrone V; Pergola M Clin Ter; 1966 Oct; 39(2):123-36. PubMed ID: 4871417 [No Abstract] [Full Text] [Related]
52. [Tumors in infants and children]. Erdös Z; Szöke L; Szeder M; Török A Monatsschr Kinderheilkd (1902); 1969 May; 117(5):415-8. PubMed ID: 4331232 [No Abstract] [Full Text] [Related]
53. [Treatment of malignant tumors in infants with antineoplastic agents]. Taguchi N Naika; 1968 Sep; 22(3):634-9. PubMed ID: 4303515 [No Abstract] [Full Text] [Related]
54. [Mitomycin alone and in therapeutic association in the palliative treatment of solid tumors]. Gary-Bobo J J Radiol Electrol Med Nucl; 1971 Dec; 52(12):858-62. PubMed ID: 4113798 [No Abstract] [Full Text] [Related]
55. [Vinca alkaloids, a newer group of anti-neoplastic drugs]. Hansen I; Nissen NI Ugeskr Laeger; 1972 Jun; 134(25):1315-21. PubMed ID: 4340246 [No Abstract] [Full Text] [Related]
56. Clinical trials with adriamycin. Middleman E; Luce J; Frei E Cancer; 1971 Oct; 28(4):844-50. PubMed ID: 5111740 [No Abstract] [Full Text] [Related]
57. [Value of vincaleukoblastine in the treatment of Hodgkin's disease and other hematosarcomas and leukemias]. Mathé G; Schweisguth O; Schneider M; Amiel JL; Cattan A; Schwarzenberg L; Brulé G; Smadja R Sem Ther; 1964 May; 40(5):320-4. PubMed ID: 4861409 [No Abstract] [Full Text] [Related]
58. [Chemotherapy of cutaneous tumors]. Nannelli M G Ital Dermatol Minerva Dermatol; 1970 Feb; 45(2):94-6. PubMed ID: 4910396 [No Abstract] [Full Text] [Related]
59. [Inhibition of mitosis by vinca alkaloids in malignant systemic skin diseases]. Goerz G; Haensch R Dtsch Med Wochenschr; 1969 May; 94(19):998-9 passim. PubMed ID: 4888720 [No Abstract] [Full Text] [Related]
60. [Chemotherapy of malignant tumors using massive-dose administration of Endoxan]. Pigatto JC Munch Med Wochenschr; 1967 Oct; 109(40):2082-4. PubMed ID: 4873942 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]